A detailed history of Polen Capital (Polen Capital Management LLC) transactions in Eli Lilly & CO stock. As of the latest transaction made, Polen Capital Management LLC holds 584,806 shares of LLY stock, worth $450 Million. This represents 1.05% of its overall portfolio holdings.

Number of Shares
584,806
Previous 594,801 1.68%
Holding current value
$450 Million
Previous $347 Million 31.22%
% of portfolio
1.05%
Previous 0.83%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$592.2 - $792.28 $5.92 Million - $7.92 Million
-9,995 Reduced 1.68%
584,806 $455 Million
Q4 2023

Feb 13, 2024

SELL
$525.19 - $619.13 $15.2 Million - $18 Million
-29,011 Reduced 4.65%
594,801 $347 Million
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $271 Million - $374 Million
623,812 New
623,812 $335 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $732B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track Polen Capital's Portfolio

Track Polen Capital Portfolio

Follow Polen Capital (Polen Capital Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polen Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Polen Capital Management LLC and Polen Capital with notifications on news.